TGAオーストラリア供給不足情報(6月3日~6月9日)

Active ingredientsDosage formQuantity of active ingredientsShortage statusAvailabilityReasonLast updated
framycetin sulfate~dexamethasone~gramicidinEar Drops5 mg/mL~.5 mg/mL~.05 mg/mLCurrentLimited AvailabilityManufacturing7/06/2024
sodium fluorideInjection, concentrated1 mg/mLCurrentLimited AvailabilityManufacturing7/06/2024
olanzapineTablet, film coated7.5 mgCurrentUnavailableManufacturing7/06/2024
vincristine sulfateInjection, solution1 mg/mLAnticipatedAvailableManufacturing7/06/2024
ethinylestradiol~drospirenoneTablet30 microgram~3 mgAnticipatedAvailableManufacturing7/06/2024
carmustineInjection, powder for100 mgAnticipatedAvailableManufacturing7/06/2024
atorvastatin calcium trihydrate~ezetimibeTablet, multilayer21.7 mg~10 mgCurrentUnavailableManufacturing7/06/2024
pemetrexed disodiumInjection, powder for1102.9 mgResolvedAvailableUnexpected increase in demand due to other sponsors unable to supply7/06/2024
desvenlafaxine benzoateTablet, modified release73.16 mgAnticipatedAvailableManufacturing7/06/2024
clindamycin phosphate~tretinoinGel12 mg~.25 mgResolvedAvailableManufacturing7/06/2024
hydrochlorothiazide~irbesartanTablet, film coated12.5 mg~150 mgDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability7/06/2024
amlodipine besilate~olmesartan medoxomilTablet, film coated6.935 mg~40 mgCurrentLimited AvailabilityTransport / Logistic issues / Storage capacity issues7/06/2024
bortezomibInjection, powder for3.5 mgDiscontinuedReduction in supply until supply is exhaustedCommercial Changes / Commercial viability7/06/2024
mercaptopurine monohydrateTablet50 mgCurrentLimited AvailabilityManufacturing7/06/2024
ezetimibe~atorvastatin calcium trihydrateTablet, film coated10 mg~41.363 mgAnticipatedAvailableManufacturing7/06/2024
prasugrelTablet, film coated5 mgAnticipatedAvailableManufacturing7/06/2024
thiotepaInjection, powder for100 mgCurrentUnavailableCommercial Changes / Commercial viability7/06/2024
oxycodone hydrochlorideCapsule, hard10 mgDiscontinuedUnavailableCommercial Changes / Commercial viability7/06/2024
famotidineTablet, film coated40 mgCurrentLimited AvailabilityManufacturing7/06/2024
acetylcholine chlorideSolution, powder for irrigation10 mg/mLCurrentUnavailableManufacturing6/06/2024
adrenaline (epinephrine) acid tartrate~lidocaine hydrochlorideInjection, solution9.1 microgram/mL~20 mg/mLResolvedAvailableManufacturing6/06/2024
hydroxocobalamin chlorideInjection, solution1.027 mgCurrentLimited AvailabilityTransport / Logistic issues / Storage capacity issues6/06/2024
insulinInjection, solution100 IU/mLCurrentLimited AvailabilityManufacturing6/06/2024
methotrexateInjection, solution2.5 mg/mLCurrentLimited AvailabilityManufacturing6/06/2024
betamethasone acetate~betamethasone sodium phosphateInjection, suspension3 mg/mL~3.9 mg/mLCurrentLimited AvailabilityProduct recall6/06/2024
quetiapine fumarateTablet, film coated28.78 mgCurrentUnavailableManufacturing6/06/2024
enoxaparin sodiumInjection, solution60 mgCurrentUnavailableTransport / Logistic issues / Storage capacity issues6/06/2024
arginine hydrochlorideInjection, intravenous infusion600 mg/mLResolvedAvailableManufacturing6/06/2024
Insulin degludec~Insulin aspartInjection, solution420 nmol/mL~180 nmol/mLCurrentLimited AvailabilityManufacturing6/06/2024
tadalafilTablet, film coated5 mgCurrentLimited AvailabilityManufacturing6/06/2024
lidocaine hydrochlorideInjection, solution400 mgCurrentUnavailableManufacturing6/06/2024
octreotideInjection, modified release10 mgDiscontinuedUnavailableCommercial Changes / Commercial viability6/06/2024
octreotideInjection, modified release30 mgDiscontinuedUnavailableManufacturing6/06/2024
octreotideInjection, modified release20 mgDiscontinuedUnavailableCommercial Changes / Commercial viability6/06/2024
levodopa~carbidopa monohydrateTablet, modified release200 mg~54 mgAnticipatedAvailableManufacturing6/06/2024
estradiolDrug delivery system, transdermal.78 mgCurrentLimited AvailabilityManufacturing6/06/2024
cabazitaxelInjection, concentrated60 mgResolvedAvailableManufacturing6/06/2024
amlodipine besilate~olmesartan medoxomilTablet, film coated6.94 mg~40 mgCurrentLimited AvailabilityUnexpected increase in consumer demand6/06/2024
bortezomibInjection, powder for3.5 mgDiscontinuedUnavailableCommercial Changes / Commercial viability6/06/2024
naproxenTablet, uncoated250 mgCurrentUnavailableManufacturing6/06/2024
diltiazem hydrochlorideCapsule, modified release240 mgResolvedAvailableManufacturing6/06/2024
sodium oxidronateInjection, powder for3.15 mgCurrentUnavailableManufacturing6/06/2024
ganciclovir sodiumInjection, powder for543 mgCurrentLimited AvailabilityManufacturing5/06/2024
hydrochlorothiazide~enalapril maleateTablet, uncoated6 mg~20 mgResolvedAvailableManufacturing5/06/2024
isoniazidTablet, uncoated100 mgCurrentUnavailableManufacturing5/06/2024
sodium pyrophosphateInjection, powder for30 mgCurrentUnavailableManufacturing5/06/2024
midazolamInjection, solution5 mgAnticipatedAvailableManufacturing5/06/2024
hydrochlorothiazide~telmisartanTablet, film coated12.5 mg~80 mgCurrentUnavailableManufacturing5/06/2024
metformin hydrochlorideTablet, modified release1000 mgCurrentLimited AvailabilityManufacturing5/06/2024
entecavirTablet, film coated1 mgResolvedAvailableManufacturing5/06/2024
Insulin aspartInjection, solution100 U/mLCurrentUnavailableTransport / Logistic issues / Storage capacity issues5/06/2024
oxycodone hydrochlorideInjection, solution10 mg/mLCurrentUnavailableCommercial Changes / Commercial viability5/06/2024
ganciclovir sodiumInjection, powder for546 mgAnticipatedAvailableManufacturing5/06/2024
tadalafilTablet, film coated5 mgCurrentUnavailableManufacturing5/06/2024
cisplatinInjection, concentrated1 mg/mLCurrentUnavailableUnexpected increase in consumer demand5/06/2024
cisplatinInjection, concentrated1 mg/mLCurrentUnavailableUnexpected increase in consumer demand5/06/2024
dasatinibTablet, film coated50 mgCurrentUnavailableTransport / Logistic issues / Storage capacity issues5/06/2024
latanoprostEye Drops, solution.05 mg/mLCurrentUnavailableManufacturing5/06/2024
timolol maleate~latanoprostEye Drops, solution6.83 mg/mL~.05 mg/mLResolvedAvailableManufacturing5/06/2024
lacosamideTablet, film coated50 mgCurrentUnavailableManufacturing5/06/2024
gliclazideTablet, modified release30 mgCurrentUnavailableManufacturing5/06/2024
acalabrutinibCapsule, hard100 mgDiscontinuedUnavailableTransport / Logistic issues / Storage capacity issues5/06/2024
medroxyprogesterone acetateTablet, uncoated10 mgResolvedAvailableManufacturing5/06/2024
cisplatinInjection, solution1 mg/mLAnticipatedAvailableUnexpected increase in consumer demand5/06/2024
tretinoinCapsule, soft10 mgCurrentLimited AvailabilityTransport / Logistic issues / Storage capacity issues5/06/2024
clarithromycinOral Liquid, powder for50 mg/mLCurrentLimited AvailabilityUnexpected increase in consumer demand5/06/2024
ketamine hydrochlorideInjection, solution115.3 mg/mLCurrentLimited AvailabilityManufacturing5/06/2024
diltiazem hydrochlorideTablet, film coated60 mgAnticipatedAvailableManufacturing5/06/2024
famotidineTablet, film coated20 mgCurrentLimited AvailabilityManufacturing5/06/2024
Coxiella burnetiiInjection50 microgram/mLCurrentLimited AvailabilityManufacturing4/06/2024
Coxiella burnetiiInjection5 microgram/mLCurrentLimited AvailabilityManufacturing4/06/2024
lisinopril dihydrateTablet, uncoated10.89 mgAnticipatedAvailableTransport / Logistic issues / Storage capacity issues4/06/2024
fludarabine phosphateInjection, concentrated50 mgCurrentUnavailableManufacturing4/06/2024
benzathine benzylpenicillin tetrahydrateInjection, suspension1200000 USP UnitResolvedAvailableUnexpected increase in consumer demand4/06/2024
sildenafil citrateTablet, film coated28.1 mgAnticipatedAvailableTransport / Logistic issues / Storage capacity issues4/06/2024
candesartan cilexetil~hydrochlorothiazideTablet, uncoated32 mg~25 mgResolvedAvailableTransport / Logistic issues / Storage capacity issues4/06/2024
ziprasidone hydrochlorideCapsule, hard65.16 mgCurrentUnavailableTransport / Logistic issues / Storage capacity issues4/06/2024
aciclovir sodium dihydrateInjection, powder for628.8 mgAnticipatedAvailableUnexpected increase in demand due to other sponsors unable to supply4/06/2024
mesalazineTablet, enteric coated800 mgCurrentLimited AvailabilityTransport / Logistic issues / Storage capacity issues4/06/2024
tadalafilTablet, film coated5 mgCurrentUnavailableUnexpected increase in demand due to other sponsors unable to supply4/06/2024
teriflunomideTablet, film coated14 mgCurrentLimited AvailabilityManufacturing4/06/2024
carbetocinInjection, solution100 microgramResolvedAvailableManufacturing4/06/2024
tazobactam sodium~piperacillin sodiumInjection, powder for536.6 mg~4.17 gResolvedAvailableManufacturing4/06/2024
isotretinoinCapsule, soft20 mgResolvedAvailableManufacturing4/06/2024
bendamustine hydrochloride monohydrateInjection, powder for25 mgCurrentLimited AvailabilityUnexpected increase in demand due to other sponsors unable to supply4/06/2024
rifampicinCapsule, hard150 mgCurrentUnavailableManufacturing4/06/2024
rifampicinCapsule, hard300 mgCurrentLimited AvailabilityManufacturing4/06/2024
lidocaine hydrochloride monohydrateInjection, solution20 mg/mLAnticipatedAvailableManufacturing4/06/2024
Insulin lisproInjection, solution100 IU/mLCurrentLimited AvailabilityManufacturing4/06/2024
raltitrexedInjection, powder for2 mgAnticipatedAvailableUnexpected increase in consumer demand4/06/2024
desonideLotion.5 mg/gCurrentLimited AvailabilityManufacturing4/06/2024
midazolamInjection, solution5 mg/mLCurrentLimited AvailabilityManufacturing4/06/2024
tobramycinInhalation, conventional60 mg/mLCurrentUnavailableManufacturing4/06/2024
gliclazideTablet, modified release30 mgCurrentLimited AvailabilityManufacturing3/06/2024
lercanidipine hydrochlorideTablet, film coated20 mgCurrentLimited AvailabilityManufacturing3/06/2024
duloxetine hydrochlorideCapsule, enteric33.65 mgCurrentUnavailableManufacturing3/06/2024
cinacalcet hydrochlorideTablet99.191 mgCurrentLimited AvailabilityManufacturing3/06/2024
2024年6月10日
このページの先頭へ戻る